Also, in addition to HER2, chromosome 17 includes other genes involved in BC pathogenesis and DNA repair, such as BRCA1, TOP2A, TP53, and RAD51C (95, 96); therefore, various abnormalities of chromosome 17 may affect prognosis and treatment response. This evidence concerns the gene ERBB2 and breast cancer.